Prasugrel

In the US, Prasugrel (prasugrel systemic) is a member of the drug class platelet aggregation inhibitors and is used to treat Acute Coronary Syndrome.

US matches:

• Prasugrel

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AC22

CAS registry number (Chemical Abstracts Service)

0150322-43-3

Chemical Formula

C20-H20-F-N-O3-S

Molecular Weight

373

Therapeutic Categories

Treatment of coronary heart disease

Antiplatelet agent, inhibiting adenosine diphosphate-mediated platelet aggregation

Chemical Names

2-Acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine

5-[(1RS)-2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate (WHO)

Ethanone, 2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)-

Foreign Names

• Prasugrelum (Latin)
• Prasugrel (German)
• Prasugrel (French)
• Prasugrel (Spanish)

Generic Names

• CS-747 (IS)
• Prasugrel hydrochloride (OS: USAN)
• LY 640315 (IS)

Brand Names

• Efient
  Lilly, Greece



• Effient
  Lilly, Australia; Lilly, United States



• Efient
  Eli Lilly, United Kingdom; Lilly, Austria; Lilly, Switzerland; Lilly, Germany; Lilly, Spain; Lilly, Finland; Lilly, France; Lilly, Sweden; Lilly, Slovakia; Lilly, United States

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.